Treatment of patients with rare diseases and requiring permanent replacement therapy (27 03 03 06) State procurement of plasma antihemophilic factor VIII concentrate (financing will be carried out within the allocations approved by the 2027 state budget). VIII concentrate (financing will be carried out within the appropriations app...
- Agency
- georgia_procurement
- Full Agency
- LEPL National Health Agency
- Country
- Georgia
- Deadline
- 15-Oct-2026 12:00
- Published
- 10-Sep-2026
- Reference
- 700757
- Est. Value
- 3190270
- Source ID
- NAT260019065
Notice Overview
Treatment of patients with rare diseases and requiring permanent replacement therapy (27 03 03 06) State procurement of plasma antihemophilic factor VIII concentrate (financing will be carried out within the allocations approved by the 2027 state budget). VIII concentrate (financing will be carried
View the full notice
Full description, contacts and procurement documents are available to signed-in members.